Xconomy: Xeljanz News, Articles and Opinions

“xeljanz” Archives

Entry	Author	Date	Location
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss	Ben Fidler	09/03/19	Boston
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis	Sarah de Crescenzo	08/16/19	National
Four New Drugs Are Around the Corner. Here’s What You Need to Know.	Ben Fidler	08/15/19	National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark	Ben Fidler	03/01/19	National
GSK Deepens Ties With Electro-Stim Startup SetPoint in $15M Funding	Ben Fidler	09/08/15	San Francisco
Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Healthy Are Your Market Access Programs?
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Archbow Consulting

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!